Testosterone replacement therapy (TRT) is prescribed for men with clinically confirmed hypogonadism due to specific pathology, characterized by low serum testosterone levels and associated symptoms such as reduced libido, fatigue, decreased muscle mass, and mood changes
It remains an investigational medicinal product, and therefore there is no official MHRA prescribing information, Summary of Product Characteristics (SmPC), or NICE guidance specific to retatrutide
"There are case reports of melanoma developing in people using melanotan, which makes biological sense, as it persistently stimulates pigment cells to proliferate." Melanotan II can also make a skin check really confusing
of cold water once daily or as directed by a healthcare professional
This is not a unique phenomenon to GLP-1 medications and is similar to what we observe with medications that treat other chronic conditions, like high blood pressure, asthma, or inflammatory bowel disease, Maselli says
